Medexus Pharmaceuticals (OTCMKTS:MEDXF) Trading Up 2.5%

Medexus Pharmaceuticals Inc. (OTCMKTS:MEDXF – Get Rating)’s stock price was up 2.5% during trading on Monday . The stock traded as high as $0.93 and last traded at $0.93. Approximately 10,000 shares were traded during mid-day trading, a decline of 27% from the average daily volume of 13,728 shares. The stock had previously closed at $0.91.

Analysts Set New Price Targets

Several equities research analysts have recently issued reports on MEDXF shares. Raymond James raised their price target on shares of Medexus Pharmaceuticals from C$3.50 to C$4.00 in a research note on Friday, March 10th. Stifel Nicolaus lowered shares of Medexus Pharmaceuticals from a “buy” rating to a “hold” rating in a research note on Thursday, February 9th.

Medexus Pharmaceuticals Stock Performance

The company’s 50 day moving average price is $1.04 and its 200-day moving average price is $1.29.

About Medexus Pharmaceuticals

(Get Rating)

Medexus Pharmaceuticals, Inc operates as a pharmaceutical company, which provides healthcare products to Healthcare Professionals and patients and focuses on therapeutic areas of auto-immune disease and pediatrics. The firm products include Rasuvo, Ixinity and Triamcinolone Hexacetonide. The company was founded by Sylvain Chretien in January 2008 and is headquartered in Bolton, Canada.